Sticker shock: AARP says drug prices doubled in 7 yrs

Advocacy group for senior citizens finds retail prescription costs increasing six times faster than inflation

• Feb 29, 2016

Martin Shkreli offers to buy Kanye's new album for $10M

Former pharmaceutical CEO doesn't want anyone else to own the album -- except for him

• Feb 11, 2016

Martin Shkreli sued over Wu-Tang Clan album

Artist says portraits of hip-hop group used without authorization on album former pharmaceutical CEO bought for $2 million

• Feb 9, 2016

Martin Shkreli appears to weigh in on White House race

Controversial ex-pharmaceutical executive's Twitter account goes political

• Feb 6, 2016

Photos of the week

The most compelling photos from the week's news, including the Australian Open, a vulture accused of being a spy and the Iowa caucuses

• Feb 5, 2016
• 33 photos

Vilified drug CEO stonewalls Congress, later does video chat with public

Congress wasn't the only one Martin Shkreli refused to answer questions from -- he also hung up on CBS News during the video chat

• Feb 4, 2016

Even muzzled, Martin Shkreli still annoys lawmakers

Former pharmaceutical CEO calls lawmakers "imbeciles" and declined to answer questions at hearing on drug price hikes; later conducted web conference

• Feb 4, 2016

The many smirks of Martin Shkreli

Former hedge fund manager and pharmaceutical CEO irks lawmakers

• Feb 4, 2016
• 11 photos

Muzzled by lawyer, Martin Shkreli to get DC earful

Congress may not get answers Thursday about his 5,000 percent drug price hike, but he sure talked on Wednesday

• Feb 3, 2016

Martin Shkreli-style drug price hikes are everywhere

Turing Pharmaceuticals' bad boy CEO has plenty of company among drugmakers raising prices outrageously

• Feb 2, 2016

Martin Shkreli beefs with Ghostface Killah, TMZ

​Martin Shkreli keeps stirring the pot, and this time, his beef is with both rapper Ghostface Killah and TMZ

• Jan 29, 2016

Lawmakers reschedule hearing to grill Martin Shkreli

Lawmakers reschedule hearing to grill Martin Shkreli

• Jan 25, 2016

Lawmakers postpone hearing to question Martin Shkreli

Former pharmaceutical CEO reviled for hiking the price of a lifesaving drug gets a snow day due to weekend blizzard

• Jan 25, 2016

Lawmaker blasts Martin Shkreli over subpoena inaction

Indicted pharmaceutical CEO reviled for hiking price of life-saving drug, has not made legal arrangements to appear before Congress next week

• Jan 21, 2016

Price-hiking pharma exec subpoenaed by House

Former Turing Pharmaceuticals CEO Martin Shkreli, reviled for price-gouging, forced to appear at a congressional hearing next Tuesday

• Jan 20, 2016

​Drugmakers ring in 2016 with hefty price hikes

Big pharma is busily raising prices on dozens of medications, branded and generic, with increases of 20 percent or more

• Jan 12, 2016

​How much is Martin Shkreli worth? At least $45 million

At 32 years old, the 'most hated man in America' has amassed a fortune in one E-Trade account alone

• Jan 8, 2016

​KaloBios' next move: Filing for bankruptcy

Just two weeks after former CEO Martin Shkreli's arrest, the biotech is now seeking bankruptcy protection

• Dec 30, 2015

​KaloBios says it is appealing Nasdaq delisting

Biotech firm was run by Martin Shkreli; he was fired earlier this month after being arrested and charged for alleged securities fraud

• Dec 29, 2015

Turing cuts jobs, looks for new CEO after Shkreli left

Shkreli resigned Friday, a day after his arrest on charges of securities fraud related to a company he previously ran

• Dec 23, 2015

Martin Shkreli out at another drug company

KaloBios says it canned the controversial hedge fund investor the day he was arrested and charged with securities fraud

• Dec 21, 2015

Shkreli takes to Twitter to speak out on charges

Feds accuse controversial ex-CEO of looting pharmaceutical company he founded to pay back disgruntled hedge fund clients

• Dec 19, 2015

Martin Shkreli resigns from Turing Pharmaceuticals

A day after his arrest on securities fraud charges, the boyish entrepreneur who drew public ire, steps down

• Dec 18, 2015

Feds: Shkreli ran companies like a Ponzi scheme

Authorities accuse former hedge fund manager who jacked up price of life-saving drug of weaving "outrageous web of lies"

• Dec 17, 2015

For Martin Shkreli, suspicions going back years

Now charged with running a Ponzi scheme, controversial pharmaceutical executive was previously accused of market misdeeds

• Dec 17, 2015

Show More